Hwail Pharm

061250 · KOSDAQ · Health Care · SMALL CAP

A capital raise.

Hwail Pharm disclosed a private placement (third-party allotment) to raise US$7.33M, about 18.4% of its market value.

Capital raise(Material event report (rights offering))· FILED 2026-09-15· RCEPT 20260915000380

US$7.33MRaise amount
18.4%vs. market value

Converted at 1 USD ≈ ₩1,363.57 (filing-date rate, 2026-09-15 close)

What happened

Hwail Pharm disclosed a private placement (third-party allotment) to raise US$7.33M, about 18.4% of its market value.

For context, this raise equals about 18.4% of the company's market value, which is the rough scale of potential new-share dilution.

InstrumentPrivate placement
Raise amountUS$7.33M
vs. market value18.4%
Filed2026-09-15, Material event report (rights offering)
SourceDART rcept 20260915000380 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-09-15 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.